Current antiretroviral therapy (ART) effectively suppresses Human Immunodeficiency Virus
type 1 (HIV-1) in infected individuals. However, even long term ART does not eradicate HIV …

Chronic inflammatory diseases, such as rheumatoid arthritis (RA), systemic lupus
erythematosus (SLE), and psoriasis and infections, such as periodontal disease and HIV …

Background Life expectancy in adults with human immunodeficiency virus (HIV) has
increased and managing other health conditions is increasingly important for patients and …

Objectives To estimate the burden of non‐communicable diseases (NCDs) and mortality
among PLHIV in the pre‐, early‐and late‐HAART (highly active antiretroviral therapy) era …

In this review, we propose that vascular cognitive impairment (VCI), with relevance for the
global HIV population, is fundamentally and clinically linked to the persistence of mild forms …

Objectives This paper aims to address the concerns around ongoing immune activation,
inflammation, and resistance in those ageing with HIV that represent current challenges for …

Women are grossly underrepresented in human immunodeficiency virus (HIV) clinical and
translational research. This is concerning given that people with HIV (PWH) are living …

Premature end-organ disease among PLWH has been repeatedly associated with higher
levels of blood biomarkers reflecting inflammation and immune activation, which, despite …

People with human immunodeficiency virus (HIV) infection (PWH) have an increased risk of
cardiovascular disease (CVD), compared with the general population. In a nested case …

Background HIV continues to be a major global health issue. The relative risk of
cardiovascular disease (CVD) among people living with HIV (PLWH) was 2.16 compared to …